Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells

Neuroscience

Volumn 179, Issue , 2011, Pages 73-79

  Lin, D ^a,b   Li, G ^a,c   Zuo, Z ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glycogen synthase kinase 3 ; Human neuron like cell; Neuroprotection; Post conditioning; Volatile anesthetics

Indexed keywords

CHIR 98014; CHIR 99021; DESFLURANE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; ISOFLURANE; LACTATE DEHYDROGENASE; OXYGEN; SERINE; SEVOFLURANE; UNCLASSIFIED DRUG;

ARTICLE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; REPERFUSION;

ANESTHETICS, INHALATION; BLOTTING, WESTERN; CELL LINE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISCHEMIC POSTCONDITIONING; ISOFLURANE; METHYL ETHERS; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 79952618826     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.055     Document Type: Article

References (34)

1. Bhat R.V., Shanley J., Correll M.P., Fieles W.E., Keith R.A., Scott C.W., Lee C.M. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A 2000, 97:11074-11079.
2. Cohen M.V., Yang X.M., Downey J.M. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007, 115:1895-1903.
3. Feng J., Lucchinetti E., Ahuja P., Pasch T., Perriard J.C., Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005, 103:987-995.
4. Gao X., Zhang H., Takahashi T., Hsieh J., Liao J., Steinberg G.K., Zhao H. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 2008, 105:943-955.
5. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008, 117:2761-2768.
6. Gosens R., Dueck G., Rector E., Nunes R.O., Gerthoffer W.T., Unruh H., Zaagsma J., Meurs H., Halayko A.J. Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1348-L1358.
7. Gross G.J., Auchampach J.A. Reperfusion injury: does it exist?. J Mol Cell Cardiol 2007, 42:12-18.
8. Isagawa T., Mukai H., Oishi K., Taniguchi T., Hasegawa H., Kawamata T., Tanaka C., Ono Y. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta. Biochem Biophys Res Commun 2000, 273:209-212.
9. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004, 113:1535-1549.
10. Juhaszova M., Wang S., Zorov D.B., Nuss H.B., Gleichmann M., Mattson M.P., Sollott S.J. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann N Y Acad Sci 2008, 1123:197-212.
11. Juhaszova M., Zorov D.B., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009, 104:1240-1252.
12. Kim J., Li L., Zuo Z. Delayed treatment with isoflurane attenuates lipopolysaccharide and interferon ? -induced activation and injury of mouse microglial cells. Anesthesiology 2009, 111:566-573.
13. Kim J.A., Li L., Zuo Z. Isoflurane induces a postconditioning effect on bovine pulmonary arterial endothelial cells exposed to oxygen-glucose deprivation. Eur J Pharmacol 2009, 615:144-149.
14. Korde A.S., Pettigrew L.C., Craddock S.D., Pocernich C.B., Waldmeier P.C., Maragos W.F. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J Neurotrauma 2007, 24:895-908.
15. Kume T., Kawato Y., Osakada F., Izumi Y., Katsuki H., Nakagawa T., Kaneko S., Niidome T., Takada-Takatori Y., Akaike A. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett 2008, 443:199-203.
16. Lee J.J., Li L., Jung H.-H., Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008, 108:1055-1062.
17. Li L., Peng L., Zuo Z. Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain. Eur J Pharmacol 2008, 586:106-113.
18. Lin D, Feng C, Cao M, Zuo Z (in press) Volatile anesthetics may not induce significant toxicity to human neuron-like cells. Anesth Analg; Epub ahead of print. PMID no: 20966438.
19. Matsui T., Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005, 38:63-71.
20. Miura T., Nishihara M., Miki T. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury. J Pharmacol Sci 2009, 109:162-167.
21. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
22. Petit-Paitel A., Brau F., Cazareth J., Chabry J. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons. PLoS One 2009, 4:e5491.
23. Petronilli V., Penzo D., Scorrano L., Bernardi P., Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 2001, 276:12030-12034.
24. Ring D.B., Johnson K.W., Henriksen E.J., Nuss J.M., Goff D., Kinnick T.R., Ma S.T., Reeder J.W., Samuels I., Slabiak T., Wagman A.S., Hammond M.E., Harrison S.D. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 2003, 52:588-595.
25. Sasaki T., Han F., Shioda N., Moriguchi S., Kasahara J., Ishiguro K., Fukunaga K. Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model. Brain Res 2006, 1108:98-106.
26. Wang Q, Chen Q, Ding Q, Yang Q, Peng Y, Lu Y, Deng J, Xiong L (in press) Sevoflurane postconditioning attenuates spinal cord reperfusion injury through free radicals-mediated up-regulation of antioxidant enzymes in rabbits. J Surg Res.
27. Wu X., Lin D., Li G., Zuo Z. Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells. Eur J Pharmacol 2010, 636:114-120.
28. Xie Z., Dong Y., Maeda U., Moir R.D., Xia W., Culley D.J., Crosby G., Tanzi R.E. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007, 27:1247-1254.
29. Xu X., Feng J., Zuo Z. Isoflurane preconditioning reduces the rat NR8383 macrophage injury induced by lipopolysaccharide and interferon gamma. Anesthesiology 2008, 108:643-650.
30. Zhao H., Sapolsky R.M., Steinberg G.K. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006, 26:1114-1121.
31. Zhao H. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 2009, 29:873-885.
32. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
33. Zhou Y., Lekic T., Fathali N., Ostrowski R.P., Martin R.D., Tang J., Zhang J.H. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. Stroke 2010, 41:1521-1527.
34. Zuo Z., Wang Y., Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006, 542:84-91.